These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 23289761)

  • 1. Tissue-preserving antibody cocktails to differentiate primary squamous cell carcinoma, adenocarcinoma, and small cell carcinoma of lung.
    Brown AF; Sirohi D; Fukuoka J; Cagle PT; Policarpio-Nicolas M; Tacha D; Jagirdar J
    Arch Pathol Lab Med; 2013 Sep; 137(9):1274-81. PubMed ID: 23289761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.
    Nishino M; Hoang MP; Della Pelle P; Morales-Oyarvide V; Huynh TG; Mark EJ; Mino-Kenudson M
    Cancer Cytopathol; 2016 Jul; 124(7):472-84. PubMed ID: 27412420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.
    Kim MJ; Shin HC; Shin KC; Ro JY
    Ann Diagn Pathol; 2013 Feb; 17(1):85-90. PubMed ID: 23040737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung.
    Whithaus K; Fukuoka J; Prihoda TJ; Jagirdar J
    Arch Pathol Lab Med; 2012 Feb; 136(2):155-62. PubMed ID: 22288962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray.
    Turner BM; Cagle PT; Sainz IM; Fukuoka J; Shen SS; Jagirdar J
    Arch Pathol Lab Med; 2012 Feb; 136(2):163-71. PubMed ID: 22288963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
    Bishop JA; Sharma R; Illei PB
    Hum Pathol; 2010 Jan; 41(1):20-5. PubMed ID: 19740516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemistry in the differential diagnostics of primary lung cancer: an investigation within the Southern Swedish Lung Cancer Study.
    Brunnström H; Johansson L; Jirström K; Jönsson M; Jönsson P; Planck M
    Am J Clin Pathol; 2013 Jul; 140(1):37-46. PubMed ID: 23765532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
    Mukhopadhyay S; Katzenstein AL
    Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of immunohistochemical and histochemical studies in the classification of lung adenocarcinoma and squamous cell carcinoma in cytologic specimens.
    Ocque R; Tochigi N; Ohori NP; Dacic S
    Am J Clin Pathol; 2011 Jul; 136(1):81-7. PubMed ID: 21685035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desmoglein-3 and Napsin A double stain, a useful immunohistochemical marker for differentiation of lung squamous cell carcinoma and adenocarcinoma from other subtypes.
    Agackiran Y; Ozcan A; Akyurek N; Memis L; Findik G; Kaya S
    Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):350-5. PubMed ID: 22495379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non-small cell lung carcinomas using fine-needle aspiration cases.
    Sharma R; Wang Y; Chen L; Gurda GT; Geddes S; Gabrielson E; Askin F; Li QK
    Hum Pathol; 2016 Aug; 54():8-16. PubMed ID: 27045515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TTF-1 and Napsin A double stain: a useful marker for diagnosing lung adenocarcinoma on fine-needle aspiration cell blocks.
    Fatima N; Cohen C; Lawson D; Siddiqui MT
    Cancer Cytopathol; 2011 Apr; 119(2):127-33. PubMed ID: 21287692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expressions of Thyroid Transcription Factor-1, Napsin A, p40, p63, CK5/6 and Desmocollin-3 in Non-Small Cell Lung Cancer, as Revealed by Imprint Cytology Using a Malinol-Based Cell-Transfer Technique.
    Kawai T; Tominaga S; Hiroi S; Kameda K; Ogata S; Nakashima H; Ozeki Y; Nakanishi K
    Acta Cytol; 2015; 59(6):457-64. PubMed ID: 26696549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of p40 (ΔNp63) with p63 and cytokeratin 5/6 immunohistochemistry in non-small cell lung carcinoma fine-needle aspiration biopsy.
    Collins BT; Wang JF; Bernadt CT
    Acta Cytol; 2013; 57(6):619-24. PubMed ID: 24107322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid transcription factor 1 and Napsin A double stain: utilizing different vendor antibodies for diagnosing lung adenocarcinoma.
    Johnson H; Cohen C; Fatima N; Duncan D; Siddiqui MT
    Acta Cytol; 2012; 56(6):596-602. PubMed ID: 23207437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromogenic immunohistochemical quadruplex provides accurate diagnostic differentiation of non-small cell lung cancer.
    Roberts EA; Morrison LE; Behman LJ; Draganova-Tacheva R; O'Neill R; Solomides CC
    Ann Diagn Pathol; 2020 Apr; 45():151454. PubMed ID: 31923744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non-small cell lung cancer.
    Ao MH; Zhang H; Sakowski L; Sharma R; Illei PB; Gabrielson E; Askin F; Li QK
    Hum Pathol; 2014 May; 45(5):926-34. PubMed ID: 24746197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal combination of immunohistochemical markers for subclassification of non-small cell lung carcinomas: A tissue microarray study of poorly differentiated areas.
    Noh S; Shim H
    Lung Cancer; 2012 Apr; 76(1):51-5. PubMed ID: 21978426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of GATA3 and p40 immunostains in the diagnosis of metastatic urothelial carcinoma in cytology specimens.
    Brandler TC; Aziz MS; Rosen LM; Bhuiya TA; Yaskiv O
    Cancer Cytopathol; 2014 Jun; 122(6):468-73. PubMed ID: 24711443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can p40 (Polyclonal) Replace p63 (Clone 4A4) in the Cytologic Diagnosis of Pulmonary Non-Small Cell Carcinoma?
    Alexander M; Chiaffarano J; Zhou F; Cangiarella J; Yee-Chang M; Simsir A
    Am J Clin Pathol; 2017 Jun; 147(6):580-588. PubMed ID: 28498881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.